Christopher J. Giuliano

Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials

Ann Lin, Christopher J. Giuliano, Ann Palladino et al. · Science Translational Medicine · 2019 · 728 citations · Full text

Structure of the mitochondrial inner membrane AAA+ protease YME1 gives insight into substrate processing

Cristina Puchades, Anthony J. Rampello, Mia Shin et al. · Science · 2017 · 233 citations · Full text

B-cell-specific checkpoint molecules that regulate anti-tumour immunity

Lloyd Bod, Yoon-Chul Kye, Jingwen Shi et al. · Nature · 2023 · 149 citations · Full text

Cancer Immunosurveillance, B-cell-specific Checkpoint Molecules, Immunology +5

CRISPR/Cas9 mutagenesis invalidates a putative cancer dependency targeted in on-going clinical trials

Ann Lin, Christopher J. Giuliano, Nicole M. Sayles et al. · eLife · 2017 · 139 citations · Full text

Putative Cancer Dependency, Breast Oncology, Engineering +20

Generating Single Cell–Derived Knockout Clones in Mammalian Cells with CRISPR/Cas9

Christopher J. Giuliano, Ann Lin, Vishruth Girish et al. · Current Protocols in Molecular Biology · 2019 · 121 citations · Full text

Medicine, Genetics, Natural Sciences +12